227 related articles for article (PubMed ID: 22845402)
1. New frontiers in therapeutic resistance in cancer.
Sartore-Bianchi A; Delorenzi M; Gagnon-Kugler T; Rousseau C; Batist G
Expert Rev Anticancer Ther; 2012 Jul; 12(7):877-9. PubMed ID: 22845402
[TBL] [Abstract][Full Text] [Related]
2. Cancer Therapeutic Resistance: Progress and Perspectives (April 7-8, 2016 - Barcelona, Spain).
Hutchinson E; Pujana MA; Arribas J
Drugs Today (Barc); 2016 Jun; 52(6):347-54. PubMed ID: 27458611
[TBL] [Abstract][Full Text] [Related]
3. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
4. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
[TBL] [Abstract][Full Text] [Related]
5. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
Albin N; Mc Leer A; Sakhri L
Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment and cancer therapy resistance.
Sun Y
Cancer Lett; 2016 Sep; 380(1):205-15. PubMed ID: 26272180
[TBL] [Abstract][Full Text] [Related]
7. Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine.
Kim HS; Sung YJ; Paik S
Yonsei Med J; 2015 Sep; 56(5):1186-98. PubMed ID: 26256959
[TBL] [Abstract][Full Text] [Related]
8. Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine.
Tsimberidou AM
Curr Probl Cancer; 2017; 41(3):176-181. PubMed ID: 28410846
[TBL] [Abstract][Full Text] [Related]
9. [The breakthrough of personalized medicine, new hopes and new challenges].
Flippot R; Massard C; Auclin E; Azria D; Bourien H; Rochigneux P; Schernberg A; Verlingue L; Zafrani L; Vignot S
Bull Cancer; 2017 Sep; 104(9):735-743. PubMed ID: 28807365
[TBL] [Abstract][Full Text] [Related]
10. Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial.
Rodon J; Soria JC; Berger R; Batist G; Tsimberidou A; Bresson C; Lee JJ; Rubin E; Onn A; Schilsky RL; Miller WH; Eggermont AM; Mendelsohn J; Lazar V; Kurzrock R
Ann Oncol; 2015 Aug; 26(8):1791-8. PubMed ID: 25908602
[TBL] [Abstract][Full Text] [Related]
11. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
Coyne GO; Takebe N; Chen AP
Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
[TBL] [Abstract][Full Text] [Related]
12. New strategies for targeting drug combinations to overcome mutation-driven drug resistance.
Wang L; Wang H; Song D; Xu M; Liebmen M
Semin Cancer Biol; 2017 Feb; 42():44-51. PubMed ID: 27840276
[TBL] [Abstract][Full Text] [Related]
13. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
14. The evolving potential of companion diagnostics.
Khoury JD
Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
[TBL] [Abstract][Full Text] [Related]
15. Implementing personalized cancer genomics in clinical trials.
Simon R; Roychowdhury S
Nat Rev Drug Discov; 2013 May; 12(5):358-69. PubMed ID: 23629504
[TBL] [Abstract][Full Text] [Related]
16. Precision medicine and bladder cancer heterogeneity.
Ma G; Yang X; Liang Y; Wang L; Li D; Chen Y; Liang Z; Wang Y; Niu H
Bull Cancer; 2018 Oct; 105(10):925-931. PubMed ID: 30243478
[TBL] [Abstract][Full Text] [Related]
17. Limits to Personalized Cancer Medicine.
Tannock IF; Hickman JA
N Engl J Med; 2016 Sep; 375(13):1289-94. PubMed ID: 27682039
[No Abstract] [Full Text] [Related]
18. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
19. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
20. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
Arnedos M; Vielh P; Soria JC; Andre F
J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
